Jin, Jinghai et al. published their patent in 2022 |CAS: 364-12-5

The Article related to selinexor analog antitumor xop1 inhibitor preparation, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.Recommanded Product: 364-12-5

On July 7, 2022, Jin, Jinghai; Shen, Chunli; Wu, Chengde; Chen, Shuhui published a patent.Recommanded Product: 364-12-5 The title of the patent was Preparation of selinexor analogs as XOP1 inhibitors. And the patent contained the following:

The invention relates to selinexor analogs (e.g., I) pharmaceutically acceptable salts thereof; pharmaceutical preparation comprising them; and their use as XOP1 inhibitors. The experimental process involved the reaction of 5-Bromo-2-iodobenzotrifluoride(cas: 364-12-5).Recommanded Product: 364-12-5

The Article related to selinexor analog antitumor xop1 inhibitor preparation, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.Recommanded Product: 364-12-5

Referemce:
Iodide – Wikipedia,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com